Pharmacoeconomic research of using aflibercept in patients with the wet age-related macular degeneration
Purpose. To evaluate the economic and clinical results of the aflibercept and ranibizumab angiogenesis inhibitors in the treat-and-extend regimen in patients with the “wet” form of age-related macular degeneration (wAMD). Materials and methods. We analyzed cost minimization, impact on the budget and...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
Real Time Ltd
2020-03-01
|
| Colección: | Российский офтальмологический журнал |
| Materias: | |
| Acceso en línea: | https://roj.igb.ru/jour/article/view/379 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|